WIA
BIIB icon

Wetzel Investment Advisors’s Biogen BIIB Stock Holding History

Wetzel Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4
Closed -$863 – 206
2024
Q2 		$863 Hold
4
– – ﹤0.01% 830
2024
Q1 		$762 Hold
4
– – ﹤0.01% 952
2023
Q4 		$1K Buy
+4
New +$982 ﹤0.01% 924

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wetzel Investment Advisors's BIIB Position: Q3 2024 in Review

Wetzel Investment Advisors sold out of Biogen (BIIB) in Q3 2024, closing a stake of 4 shares — an estimated $863 sold.

Wetzel Investment Advisors first reported a position in BIIB in Q4 2023 and held it in 3 quarters. The position peaked at $1K in Q4 2023. 916 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Wetzel Investment Advisors reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Wetzel Investment Advisors sold 4 Biogen shares in Q3 2024, an estimated $863.
  • Wetzel Investment Advisors first reported a position in Biogen in Q4 2023 and held it in 3 quarters.
  • Wetzel Investment Advisors's Biogen position peaked at $1K in Q4 2023.
  • 916 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Wetzel Investment Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.